⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 12, 2024Combinatorial Chemistry & High Throughput Screening

Matrine: A Promising Treatment for Ulcerative Colitis by Targeting the HMGB1/NLRP3/Caspase-1 Pathway

Kexin Sun Weiye Lin Qianran Hong Shuangyu Chen Jiayang Li Shengliang Qiu

View Full Paper

Ask AI

Bookmark

Share

Abstract

Previous studies have found that matrine (MAT) effectively treated Ulcerative Colitis (UC). The purpose of this study is to explore its mechanism based on the HMGB1/NLRP3/Caspase-1 signaling pathway.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sun et al. (2024) studied this question.

synapsesocial.com/papers/68e7982fb6db64358770826b https://doi.org/10.2174/0113862073292384240209095838

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Matrine improves bile acid metabolism and reduces inflammatory and oxidative stress in colitis via the JAK2 pathwayOriginal Research · 2026 · 1 citations
2Integrated metabolomics and gut microbiota analyses reveal the protective effects of matrine in ulcerative colitisOriginal Research · 2026
3Integrating single-cell sequencing and network pharmacology to reveal the mechanisms of matrine against ulcerative colitisOriginal Research · 2026
4Matrine Ameliorates DSS-Induced Colitis by Suppressing Inflammation, Modulating Oxidative Stress and Remodeling the Gut Microbiota2024 · 37 citations
5Matrine improves bile acid metabolism and reduces inflammatory and oxidative stress in inflammatory bowel disease (IBD) via suppressing JAK2 pathway2025